Faculty Opinions recommendation of Low-Level Laser and Light-Emitting Diode Therapy for Pain Control in Hyperglycemic and Normoglycemic Patients Who Underwent Coronary Bypass Surgery with Internal Mammary Artery Grafts: A Randomized, Double-Blind Study with Follow-Up.

Author(s):  
Paul White
2017 ◽  
Vol 35 (1) ◽  
pp. 24-31 ◽  
Author(s):  
Andréa Conceição Gomes Lima ◽  
Gilderlene Alves Fernandes ◽  
Raimundo de Barros Araújo ◽  
Isabel Clarisse Gonzaga ◽  
Rauirys Alencar de Oliveira ◽  
...  

1991 ◽  
Vol 66 (02) ◽  
pp. 195-201 ◽  
Author(s):  
D W T Nilsen ◽  
K Dalaker ◽  
A Nordøy ◽  
B Østerud ◽  
O C Ingebretsen ◽  
...  

SummaryTwenty patients accepted for coronary bypass surgery were randomized to receive either a concentrated ethylester compound of n-3 fatty acids, with a daily dose of 3.15 g of eicosapentaenoic acid (EPA) and 1.89 g of docosahexaenoic acid (DHA), or corn oil (controls) in a double blind study, to evaluate the effect on lipids, platelets and coagulation during the pre- and postoperative phase.Only patients with fasting triglyceride (TG) levels ≥1.6 mmol/1 at recruitment were eligible. The study was continued for 5 to 6 months. Surgery was usually performed at mid-intervention. Blood samples were collected during morning hours in fasting subjects, just prior to intervention, preoperatively and at final postoperative follow-up. Moreover, blood loss was accurately accounted for postoperatively.A threefold increase (p = 0.0001) of EPA was noted at pre-and postoperative follow-up. TG-levels were reduced 20 and 39%, respectively, in patients on n-3 fatty acids, reaching statistical significance at end of intervention (p = 0.034). TG-levels in controls remained largely unchanged. In patients on n-3 fatty acids, there was a statistically significant increase in serum total cholesterol preoperatively, but this change was no longer present at completion of the study.No significant changes were noted in platelet function, as judged by bleeding time, collagen induced platelet aggregation and release of TxB2 during aggregation. Parameters of extrinsic coagulation, including phospholipase C-sensitive factor VII (PLC-VII) and extrinsic pathway inhibitor (EPI), also remained essentially unchanged in both groups of patients. However, fibrinogen was significantly reduced in controls (p <0.05) at end of intervention. Moreover, a strong positive correlation was noted between PLC-VII and TG (r = 0.77, p = 0.0001).No significant difference in postoperative bleeding was noted between the two groups of patients.


Author(s):  
Husam H. Balkhy ◽  
L. Samuel Wann ◽  
Susan Arnsdorf

Introduction Traditional coronary artery bypass grafting is performed using a hand sewn technique. The C-Port xA and Flex A anastomotic stapling devices (Cardica Inc., Redwood City, CA) were cleared by the Food and Drug Administration for use in distal coronary anastomoses in November 2006 and April 2007, respectively. They provide the ability to create a compliant, consistently reproducible, and automated anastomosis. Multidetector computed tomography (CT) has been shown to be effective in evaluating coronary artery bypass graft patency. Methods The first 24 patients to undergo internal mammary artery (IMA) anastomosis using the automated device in our practice were included in the study. Twenty-five IMA grafts (24 left IMA and 1 right IMA) were created using the C-Port xA or Flex A anastomotic device as part of multivessel off-pump coronary revascularization by sternotomy. Graft patency was evaluated at 30 days in the first 10 grafts and at 90 days in the next 15 grafts using multidetector (64 slice) CT. Results There were no device failures. There were no perioperative strokes, myocardial infarctions, or deaths. All 10 IMA grafts evaluated at 30 days were patent using multidetector CT. One of the 15 IMA grafts studied at 90 days was occluded using multidetector computed tomography. Conclusions The C-Port xA and Flex A distal anastomotic devices provided a safe and effective means to create a left IMA-left anterior descending artery anastomoses in coronary bypass surgery with excellent short to midterm patency in this early experience. Long-term follow-up is warranted. These findings will have important implications for future sternal sparing coronary bypass surgery.


2008 ◽  
Vol 33 (2) ◽  
pp. 222-224 ◽  
Author(s):  
Lars Englberger ◽  
Jasmin Noti ◽  
Franz F. Immer ◽  
Mario Stalder ◽  
Friedrich S. Eckstein ◽  
...  

2007 ◽  
Vol 16 ◽  
pp. S33
Author(s):  
Phuong Markman ◽  
Michael Rowland ◽  
Jee-Yoong Leong ◽  
Silvana Marasco ◽  
Justin Negri ◽  
...  

2002 ◽  
Vol 10 (2) ◽  
pp. 160-161 ◽  
Author(s):  
Mehmet Balkanay ◽  
Denyan Mansuroğlu ◽  
Kaan Kirali ◽  
Suat Nail Ömeroğlu ◽  
Cevat Yakut

A 65-year-old man with unstable angina pectoris developed malaria prior to coronary artery bypass grafting. After 3 weeks on antimalarial therapy, left internal mammary artery-toleft anterior descending artery anastomosis was performed on the beating heart to avoid the effects of cardiopulmonary bypass. There was no complication in the early postoperative period.


1999 ◽  
Vol 117 (6) ◽  
pp. 1128-1135 ◽  
Author(s):  
Samantha L. Mullis-Jansson ◽  
Michael Argenziano ◽  
Steven Corwin ◽  
Shunichi Homma ◽  
Alan D. Weinberg ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document